Monday, January 7, 2019

#BloodSerum Lipidomic Signature of Invasive Ductal #Carcinoma and its Dependence on the Breast Cancer Evolution: A Pilot Study by Carmen Socaciu in BJSTR

Abstract

#Lipidomics, a promising detection method, may serve as a novel prognostic approach for breast cancer patients. Using high performance liquid chromatography coupled with #electrosprayionization #triplequadrupole time of flight #massspectrometry, this pilot study aims to detect the serum lipidomic signature of patients with confirmed invasive #ductalcarcinoma, at three different stages (stage I–III) comparatively to healthy controls. Two different multivariate and univariate statistical models were applied for evaluating the lipid species, by PCA, PLS-DA, AUROC and T-test, as potential #biomarkers in the diagnosis of this type of breast cancer. Our results revealed that lipid biomarkers responsible for the discrimination between breast cancer patients and healthy controls belong mainly to #diacylglycerol and #phosphatidylcholine derivatives of different unsaturated fatty acids.


For more Research and Review Articles on BJSTR



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Appraisal of Target Determination for Radiotherapeutic Management of Hepatic Tumors

  Appraisal of Target Determination for Radiotherapeutic Management of Hepatic Tumors Introduction Although not included within the group of...